New Delhi, May 08: The Drugs Controller General of India (DCGI) has given nod for the emergency use of drug 2-deoxy-D-glucose (2-DG) as an adjunct therapy in moderate to severe Covid-19 cases. "Being a generic molecule and analogue of glucose, it can